Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
No-Receipt date
2017-01736 - 19/05/2017
No-Filing date
20170401374 - 19/05/2017
No-Granting date
3092638 - 28/08/2017
No-EPO application date
11772735.4 - 21/04/2011
No-EPO granting date
2560658 - 22/02/2017
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
8/2017 - 23/10/2017
Expiration date
22/04/2031
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US326406 P21/04/2010/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07K 16/32
C07K 16/28
A61P 35/02
A61P 35/00
A61K 45/06
A61K 39/395
A61K 31/55
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
761593
VENTIRX PHARMACEUTICALS, INC.
1191 SECOND AVENUE, SUITE 1105
SEATTLE, WA 98101
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1873114
HERSHBERG, ROBERT
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8397
ANDRONIKI
MISIOU
ANALIPSEOS 23 KAI MARATHONOS 27
VRILISSIA (ATTIKIS)
15235
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
11/10/2023 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 10/2023 Αρ. Πρωτ. ΓΔ 2911 / 10.11.2023
Payments history
12 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).